Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A term that refers to teratoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, or mixed forms of these tumors.
Biomarker and diagnostic research for nongerminomatous germ cell tumor has been reported in the published literature.
11 clinical trials registered, 6 recruiting. Interventions under study include drug therapy, procedural interventions, other interventions, and biologic therapy. Pipeline includes 1 PHASE3, 6 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06133543](https://clinicaltrials.gov/study/NCT06133543) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 9:41 PM UTC
Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer |
NA |
Heinrich-Heine University, Duesseldorf |
RECRUITING |
[NCT05705687](https://clinicaltrials.gov/study/NCT05705687) | Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors | NA | Gustave Roussy, Cancer Campus, Grand Paris | RECRUITING |
[NCT04804007](https://clinicaltrials.gov/study/NCT04804007) | Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT | PHASE2 | Nabil Adra | RECRUITING |
[NCT06418789](https://clinicaltrials.gov/study/NCT06418789) | High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors | PHASE2 | N.N. Petrov National Medical Research Center of Oncology | RECRUITING |
[NCT07218913](https://clinicaltrials.gov/study/NCT07218913) | Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors | PHASE1 | City of Hope Medical Center | RECRUITING |
88 publications have been identified in PubMed for nongerminomatous germ cell tumor. Research spans Case Report / Case Series (39%), Clinical Trial Publication (22%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 34 | 39% |
Clinical study results | 19 | 22% |
Disease patterns and progression | 13 | 15% |
Research summaries | 10 | 11% |
Testing and diagnosis research | 5 | 6% |
Laboratory research | 4 | 5% |
Other research | 3 | 3% |
Kern SQ (2026). [PMID: 41820140](https://pubmed.ncbi.nlm.nih.gov/41820140/). *Clin Genitourin Cancer*. [Epidemiology / Natural History]
Mochizuki T (2026). [PMID: 41782041](https://pubmed.ncbi.nlm.nih.gov/41782041/). *J Med Case Rep*. [Case Report / Case Series]
Faure Conter C (2026). [PMID: 42115464](https://pubmed.ncbi.nlm.nih.gov/42115464/). *Adv Tech Stand Neurosurg*. [Review / Meta-Analysis]
Baccaglini W (2026). [PMID: 40952830](https://pubmed.ncbi.nlm.nih.gov/40952830/). *Int Braz J Urol*. [Case Report / Case Series]
Gao HL (2026). [PMID: 41631280](https://pubmed.ncbi.nlm.nih.gov/41631280/). *J Med Cases*. [Case Report / Case Series]
Tahuahua-Flores O (2026). [PMID: 41438535](https://pubmed.ncbi.nlm.nih.gov/41438535/). *Indian J Thorac Cardiovasc Surg*. [Case Report / Case Series]
Cheng KW (2026). [PMID: 41991382](https://pubmed.ncbi.nlm.nih.gov/41991382/). *Urol Oncol*. [Epidemiology / Natural History]
Borden ES (2026). [PMID: 41359885](https://pubmed.ncbi.nlm.nih.gov/41359885/). *J Pediatr Hematol Oncol*. [Review / Meta-Analysis]
Chen L (2026). [PMID: 42133855](https://pubmed.ncbi.nlm.nih.gov/42133855/). *Int Braz J Urol*. [Case Report / Case Series]
Mousa A (2026). [PMID: 41212998](https://pubmed.ncbi.nlm.nih.gov/41212998/). *J Urol*. [Clinical Trial Publication]